Adherence to repeat screening flexible sigmoidoscopy in the Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial

被引:24
|
作者
Weissfeld, JL
Ling, BS
Schoen, RE
Bresalier, RS
Riley, T
Prorok, PC
机构
[1] Univ Pittsburgh, Inst Canc, Pittsburgh, PA 15260 USA
[2] Henry Ford Hlth Sci Ctr, Detroit, MI USA
[3] Informat Management Syst Inc, Silver Spring, MD USA
[4] NCI, Bethesda, MD 20892 USA
关键词
flexible sigmoidoscopy; acceptability; adherence; repeat testing;
D O I
10.1002/cncr.10538
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
BACKGROUND. Acceptance of screening flexible sigmoidoscopy has been poor, in part because of providers' concerns regarding the acceptability of the procedure. In the current prospective study, the authors used adherence to repeat testing to assess the acceptability of screening flexible sigmoidoscopy. METHODS. The current study was a prospective study of a randomized clinical trial drawing volunteers from the community. Subjects included 10,164 Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial participants who were available for follow-up 3 years after undergoing a baseline screening flexible sigmoidoscopy examination. The authors measured adherence and identified those factors that appeared to affect adherence to repeat sigmoidoscopy. RESULTS. Overall, 18.3% of women and 10.0% of men did not undergo a repeat sigmoidoscopy. Among individuals who attended the Year-3 clinic, 10.4% of women and 5.1% of men specifically refused repeat sigmoidoscopy when it was offered (risk of refusal in women compared with men, 2.04; 95% confidence interval, 1.76-2.36). Another factor found to be associated with refusal included a technically inadequate baseline sigmoidoscopy. CONCLUSIONS. Gender and past experiences with sigmoidoscopy may impact adherence to repeat screening. Nonetheless, among research volunteers in a randomized clinical trial of screening, excellent adherence to repeat screening flexible sigmoidoscopy could be achieved. (C) 2002 American Cancer Society.
引用
收藏
页码:2569 / 2576
页数:8
相关论文
共 50 条
  • [1] Repeat screening flexible sigmoidoscopy in the prostate, lung, colorectal, and ovarian (PLCO) cancer screening trial.
    Weissfeld, JL
    Ling, BS
    Schoen, RE
    Bresalier, RS
    Riley, T
    [J]. GASTROENTEROLOGY, 2000, 118 (04) : A441 - A441
  • [2] Factors which affect adherence to repeat screening flexible sigmoidoscopy in the Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial.
    Weissfeld, JL
    Ling, BS
    Schoen, RE
    Bresalier, R
    Riley, T
    [J]. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2000, 9 (02) : 235 - 235
  • [3] Flexible sigmoidoscopy in the randomized prostate, lung, colorectal, and ovarian (PLCO) cancer screening trial: Colorectal cancer survival by trial arm
    Doroudi, Maryam
    Pinsky, Paul F.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [4] Flexible Sigmoidoscopy in the Randomized Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial: Added Yield from a Second Screening Examination
    Weissfeld, Joel L.
    Schoen, Robert E.
    Pinsky, Paul F.
    Bresalier, Robert S.
    Doria-Rose, V. Paul
    Laiyemo, Adeyinka O.
    Church, Timothy
    Yokochi, Lance A.
    Yurgalevitch, Susan
    Rathmell, Joshua
    Andriole, Gerald L.
    Buys, Saundra
    Crawford, E. David
    Fouad, Mona
    Isaacs, Claudine
    Lamerato, Lois
    Reding, Douglas
    Prorok, Philip C.
    Berg, Christine D.
    [J]. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2012, 104 (04) : 280 - 289
  • [5] Colorectal cancers not detected by screening flexible sigmoidoscopy in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial
    Schoen, Robert E.
    Pinsky, Paul F.
    Weissfeld, Joel L.
    Yokochi, Lance A.
    Church, Timothy
    Laiyemo, Adeyinka O.
    Bresalier, Robert
    Hickey, Tom
    Riley, Thomas
    Prorok, Philip C.
    [J]. GASTROINTESTINAL ENDOSCOPY, 2012, 75 (03) : 612 - 620
  • [6] Lung Cancer Screening in the Randomized Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial
    Hocking, William G.
    Hu, Ping
    Oken, Martin M.
    Winslow, Stephen D.
    Kvale, Paul A.
    Prorok, Philip C.
    Ragard, Lawrence R.
    Commins, John
    Lynch, David A.
    Andriole, Gerald L.
    Buys, Saundra S.
    Fouad, Mona N.
    Fuhrman, Carl R.
    Isaacs, Claudine
    Yokochi, Lance A.
    Riley, Thomas L.
    Pinsky, Paul F.
    Gohagan, John K.
    Berg, Christine D.
    [J]. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2010, 102 (10) : 722 - 731
  • [7] The prostate, lung, colorectal and ovarian (PLCO) cancer screening trial - Preface
    Gohagan, JK
    [J]. CONTROLLED CLINICAL TRIALS, 2000, 21 (06): : 249S - 250S
  • [8] Design of the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial
    Prorok, PC
    Andriole, GL
    Bresalier, RS
    Buys, SS
    Chia, D
    Crawford, ED
    Fogel, R
    Gelmann, EP
    Gilbert, F
    Hasson, MA
    Hayes, RB
    Johnson, CC
    Mandel, JS
    Oberman, A
    O'Brien, B
    Oken, MM
    Rafla, S
    Reding, D
    Rutt, W
    Weissfeld, JL
    Yokochi, L
    Gohagan, JK
    [J]. CONTROLLED CLINICAL TRIALS, 2000, 21 (06): : 273S - 309S
  • [9] Secondary prostate cancer screening outcomes by race in the Prostate, Lung, Colorectal, and Ovarian (PLCO) Screening Trial
    Miller, Eric A.
    Pinsky, Paul F.
    Black, Amanda
    Andriole, Gerald L.
    Pierre-Victor, Dudith
    [J]. PROSTATE, 2018, 78 (11): : 830 - 838
  • [10] Black participation in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial
    Stallings, FL
    Ford, ME
    Simpson, NK
    Fouad, M
    Jernigan, JC
    Trauth, JM
    Miller, DS
    [J]. CONTROLLED CLINICAL TRIALS, 2000, 21 (06): : 379S - 389S